Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.
- DOI
- 10.1038/s41467-023-42294-3
- Published
- 2023-10-13
- Container
- Nat Commun
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-023-42294-3,
title = {Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.},
author = {Petruk G and Puthia M and Samsudin F and Petrlova J and Olm F and Mittendorfer M and Hyllén S and Edström D and Strömdahl AC and Diehl C and Ekström S and Walse B and Kjellström S and Bond PJ and Lindstedt S and Schmidtchen A.},
year = {2023},
journal = {Nat Commun},
doi = {10.1038/s41467-023-42294-3},
url = {https://doi.org/10.1038/s41467-023-42294-3}
}RIS
TY - JOUR TI - Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs. AU - Petruk G AU - Puthia M AU - Samsudin F AU - Petrlova J AU - Olm F AU - Mittendorfer M AU - Hyllén S AU - Edström D AU - Strömdahl AC AU - Diehl C AU - Ekström S AU - Walse B AU - Kjellström S AU - Bond PJ AU - Lindstedt S AU - Schmidtchen A. PY - 2023 JO - Nat Commun DO - 10.1038/s41467-023-42294-3 UR - https://doi.org/10.1038/s41467-023-42294-3 ER -
APA
G, P., M, P., F, S., J, P., F, O., M, M., S, H., D, E., AC, S., C, D., S, E., B, W., S, K., PJ, B., S, L., & A., S. (2023). Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.. Nat Commun. https://doi.org/10.1038/s41467-023-42294-3
Source records
- europe-pmc · retrieved 2026-09-26T05:12:57.116Z